DRKS00009536招募中不适用
Male breast cancer - A prospective registry study the University Women's Hospital Magdeburg in cooperation with the GBG (German Breast Group) the diagnosis and treatment of breast cancer man
niversitätsfrauenklinik0 个研究点目标入组 1,000 人开始时间: 2015年10月30日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Male
入选标准
- •Patient with histologically confirmed, primary breast cancer
- •- Written consent of the patient for data collection and for the histopathological provisions on tumor tissue.
- •- Inclusion of patients can only up to the beginning of chemotherapy
- •- If no chemotherapy must be given, inclusion within 6 months is possible after surgery
排除标准
- 未提供
研究者
相似试验
招募中
不适用
A study to estimate improvement in quality of life, cost effectiveness of radiotherapy in patients of breast cancer with bone metastases.CTRI/2018/03/012317Tata Memorial Hospital
已完成
不适用
Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007Breast CancerNCT00773669Summa Health System24
进行中（未招募）
1 期
Pivotal study in breast cancer patients investigating efficacy and safety of LA-EP2006 and Neulasta®Breast CancerEUCTR2012-002039-28-ESSandoz GmbH308
已完成
3 期
A study to evaluate the Efficacy and Safety of LA-EP2006 and Neulasta® in patients with breast cancer.CTRI/2012/10/003065Sandoz GmbH302
尚未招募
不适用
Breast Cancer Screening : The prevalence of breast cancer in transgender people in Thailand.Transgender peopleBreast cancerTransgender menTransgender womenBreast cancer screeningawarenessprevalenceTCTR20200817005Center of Excellence in Transgender Health, CETH2,610